BPA CALL
Active36C24927N0149
Department of Veterans Affairs › 249-NETWORK CONTRACT OFFICE 9 (36C249)
$960.2K
obligated · signed 6 days ago
VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
Performance timeline
Start
Oct 1, 2026
End
Sep 30, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 30, 2027
ADVANCED ACCELERATOR APPLICATIONS USA INC
Contract 36C24927N0149
UEI
JNM4NBNHFE66
Parent Company
NOVARTIS SANIERUNGSSTIFTUNG
Capabilities & Certifications
Headquarters Location
Congressional District: 12
Current Obligation
$960,239
Base + Exercised Options
$960,239
Total Ceiling Value
$960,239
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 11
Awarding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
249-NETWORK CONTRACT OFFICE 9 (36C249)
Office
Funding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
VISN OFC 09(00486)
Office
Contract Vehicle
36C24925A0031
BPADepartment of Veterans Affairs
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.